Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway

由 Chocry, Mathieu, Leloup, Ludovic, Kovacic, Hervé
發表在 Oncotarget (2017)

Correction: Reversion of resistance to oxaliplatin by inhibition of p38 MAPK in colorectal cancer cell lines: involvement of the calpain / Nox1 pathway

由 Chocry, Mathieu, Leloup, Ludovic, Kovacic, Hervé
發表在 Oncotarget (2018)

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer

由 Pradhan, Monika, Chocry, Mathieu, Gibbons, Don L., Sepesi, Boris, Cascone, Tina
發表在 Transl Lung Cancer Res (2021)

Pan Aurora Kinase Inhibitor: A Promising Targeted-Therapy in Dedifferentiated Liposarcomas With Differential Efficiency Depending on Sarcoma Molecular Profile

由 Mattei, Jean Camille, Bouvier-Labit, Corinne, Barets, Doriane, Macagno, Nicolas, Chocry, Mathieu, Chibon, Frédéric, Morando, Philippe, Rochwerger, Richard Alexandre, Duffaud, Florence, Olschwang, Sylviane, Salas, Sébastien, Jiguet-Jiglaire, Carine
發表在 Cancers (Basel) (2020)